EyeGene Inc. (KOSDAQ: 185490)

EyeGene Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	499.82	5,496	2,046	2,649	2,723	3,835
Short-Term Investments	34,367	49,872	59,080	72,680	29,158	35,158
Trading Asset Securities	-	-	5,329	10,027	468.34	506.54
Cash & Short-Term Investments	34,866	55,368	66,455	85,357	32,349	39,499
Cash Growth	-22.82%	-16.68%	-22.14%	163.86%	-18.10%	-17.34%
Accounts Receivable	1,020	468.06	898.07	731.32	841.91	989.79
Other Receivables	-	428.64	486.97	296.1	49.91	132.32
Receivables	1,020	896.7	1,385	1,027	891.82	1,122
Inventory	570.68	55.21	498.01	774.4	704.49	311.13
Other Current Assets	510.74	557.51	492.77	1,485	2,172	2,217
Total Current Assets	36,968	56,877	68,830	88,644	36,117	43,150
Property, Plant & Equipment	9,741	9,851	5,742	5,864	3,549	2,308
Long-Term Investments	13,982	9,337	3,807	4,076	1,136	794.96
Other Intangible Assets	4,324	982.61	844.1	761.27	487.42	480.79
Other Long-Term Assets	2,761	1,055	1,158	5,646	3,137	575.76
Total Assets	67,776	78,103	80,381	104,991	44,427	47,309
Accounts Payable	1,556	470.69	863.84	1,894	1,530	931.89
Accrued Expenses	-	341.29	343.29	361.43	78.66	48.84
Short-Term Debt	1,699	1,498	1,392	2,995	5,234	15,066
Current Portion of Leases	401.63	314.49	392.85	272.63	228.49	267.31
Current Unearned Revenue	-	3.33	3.2	3.16	64.74	64.59
Other Current Liabilities	3,007	3,470	1,924	4,083	1,353	1,072
Total Current Liabilities	6,664	6,098	4,920	9,609	8,489	17,451
Long-Term Debt	1,507	1,056	-	-	11,516	2,520
Long-Term Leases	334.72	338.43	611.41	676.06	144.1	346.8
Long-Term Deferred Tax Liabilities	-	-	-	1,168	1,252	-
Other Long-Term Liabilities	3,254	2,791	1,281	513.64	7,716	5,786
Total Liabilities	14,375	13,769	11,426	16,022	31,528	28,279
Common Stock	13,515	13,515	10,739	10,705	5,825	5,744
Additional Paid-In Capital	188,325	188,329	176,131	176,277	70,688	62,390
Retained Earnings	-159,012	-149,862	-129,722	-103,829	-68,053	-53,258
Comprehensive Income & Other	10,304	11,248	9,580	5,816	4,440	4,153
Total Common Equity	53,132	63,230	66,728	88,969	12,899	19,030
Minority Interest	268.9	1,104	2,228	-	-	-
Shareholders' Equity	53,401	64,334	68,956	88,969	12,899	19,030
Total Liabilities & Equity	67,776	78,103	80,381	104,991	44,427	47,309
Total Debt	3,943	3,207	2,397	3,943	17,122	18,200
Net Cash (Debt)	30,923	52,161	64,058	81,413	15,228	21,299
Net Cash Growth	-23.39%	-18.57%	-21.32%	434.65%	-28.51%	-16.83%
Net Cash Per Share	1444.51	2409.77	2987.22	4298.37	1101.24	1596.09
Filing Date Shares Outstanding	27.03	27.03	21.48	21.41	13.98	13.79
Total Common Shares Outstanding	27.03	27.03	21.48	21.41	13.98	13.79
Working Capital	30,304	50,779	63,911	79,034	27,629	25,699
Book Value Per Share	1965.69	2339.28	3106.77	4155.60	922.76	1380.35
Tangible Book Value	48,808	62,248	65,884	88,208	12,412	18,549
Tangible Book Value Per Share	1805.72	2302.93	3067.47	4120.04	887.90	1345.48
Machinery	-	13,392	7,251	6,154	4,418	2,384
Construction In Progress	-	-	102.83	613.25	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.